Http://msds.farnam.com/m001830.htm

MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Return to MSDS List , First MSDS in list. , Last MSDS in list.
M A T E R I A L S A F E T Y D A T A S H E E T
Generated 07/21/2010, Revision 07/21/2010, Supercedes Revision 11/12/2009, Date
Created
11/12/2009
SECTION 1. Product and Company Identification
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Product Code: HH-IVER
Product Name:
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Reference #: ANADA
Manufacturer Information
Company Name: Distributed
Emergency Contact:
Alternate Emergency
Contact:
Information:
Preparer Name: S
Additional Identity Information
100503595 6.08g (0.21 oz) box packaging
100503652 6.08g (0.21 oz) cello packaging
SECTION 2. Composition/Information on Ingredients
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Hazardous Components (Chemical Name)
Concentration
methylpropyl)-22,23-dihydro-25-(1-methylethyl)- SECTION 3. Hazards Identification
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Emergency Overview
KEEP OUT OF REACH OF CHILDREN
Route(s) of Entry:
Inhalation? N.A. , Skin? Yes , Eyes? Yes , Ingestion? Yes Potential Health Effects (Acute and Chronic)
None known
Signs and Symptoms Of Exposure
None known
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Medical Conditions Generally Aggravated By Exposure
None known
SECTION 4. First Aid Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Emergency and First Aid Procedures
IF INGESTED: If accidental ingestion occurs, get medical attention immediately.
IF IN EYES: Immediately flush eyes with plenty of water for 15 minutes. Seek medical attention if
irritation persists.
IF ON SKIN: Wash contact area with soap and water. Remove contaminated clothing and wash before
reuse. If irritation occurs or persists, get medical attention.
Note to Physician
None
SECTION 5. Fire Fighting Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Flash Pt: NA
Explosive Limits:
Autoignition Pt: NA
Fire Fighting Instructions
Firefighters should wear self-contained breathing apparatus and full protective equipment.
Flammable Properties and Hazards
None known
Hazardous Combustion Products
None known
Extinguishing Media
Use water spray or all purpose dry chemical.
Unsuitable Extinguishing Media
None known
SECTION 6. Accidental Release Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Steps To Be Taken In Case Material Is Released Or Spilled
Shovel spill into disposal containers. Rinse spill site with detergent and water. Use suitable protective
gear.
SECTION 7. Handling and Storage
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Precautions To Be Taken in Handling
Do Not Smoke. Avoid contact with eyes, skin and clothing. Wash hands after use.
Precautions To Be Taken in Storing
Store in cool dry place away from heat and sunlight.
Other Precautions
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Refrain from smoking and eating when handling. Wash hands after use. Avoid contact with eyes.
SECTION 8. Exposure Controls/Personal Protection
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Respiratory Equipment (Specify Type)
None
Eye Protection
Wear safety goggles
Protective Gloves
Wear rubber gloves
Other Protective Clothing
None needed except for manufacturing situations or large spills of product.
Engineering Controls (Ventilation etc.)
Local exhaust sufficient.
Work/Hygienic/Maintenance Practices
Wash hands before eating, smoking, or using restroom.
SECTION 9. Physical and Chemical Properties
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Physical States:
Melting Point: NA
Boiling Point: NA
Autoignition Pt: NA
Flash Pt: NA
Explosive Limits:
Specific Gravity (Water = 1):
Density:
Bulk density:
Vapor Pressure (vs. Air or mm NA
Hg):
Vapor Density (vs. Air = 1):
Evaporation Rate (vs Butyl
Acetate=1):
Solubility in Water: No
Solubility Notes
Dispersible
Percent Volatile: NA
VOC / Volume: NA
Heat Value:
Particle Size:
Corrosion Rate:
Appearance and Odor
Clear, colorless paste
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% SECTION 10. Stability and Reactivity
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Stability:
Conditions To Avoid - Instability
NE
Incompatibility - Materials To Avoid
None known
Hazardous Decomposition Or Byproducts
None known
Hazardous Polymerization:
Conditions To Avoid - Hazardous Polymerization
None known
SECTION 11. Toxicological Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
No data available
Carcinogenicity/Other Information
Ivermectin is not listed as a carcinogen with NTP, OSHA, or IARC.
Hazardous Components (Chemical Name)
NTP IARC ACGIH OSHA
Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)- Carcinogenicity:
NTP? No IARC Monographs? No OSHA Regulated? No SECTION 12. Ecological Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Ivermectin and excreted ivermectin residues may adversely affect aquatic organisms. Do not contaminate ground or surface water. Dispose of the syringe in an approved landfill or by incineration.
SECTION 13. Disposal Considerations
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Waste Disposal Method
Dispose of in accordance with local, state and federal regulations.
SECTION 14. Transport Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
LAND TRANSPORT (US
DOT)

DOT Proper Shipping Name Not regulated as hazardous by U.S. DOT.
DOT Hazard Label: None
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% SECTION 15. Regulatory Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 16. Other Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Company Policy or Disclaimer
The information and data herein are believed to be accurate and have been compiled from sources
believed to be reliable. It is offered for your consideration, investigation and verification.

Source: http://www.horse.com/ContentFiles/Associated_Content/HHIvermectinMSDS.pdf

Microsoft word - publikationsliste-dept.g-2007-web.doc

Gesundheit Departement Gesundheit ZHAW Publikationsliste 2007 23. 05. 2008 Die fett markierten (Ko-) AutorInnen sind Mitarbeitende des Departements Gesundheit. 1. Publikationen referierten Zeitschriften (mit Peer Review) Brodbeck, J., Matter, M., Page, J. & Moggi, F. (2007). Motives for cannabis use as a moderator variable of distress among young adults.

Cd-rom

Editorial Commentary Migrainous stroke Reports of migraine-associated stroke appear in the medical literature with regularity, but uncertainty persists as to themechanisms which may generate this uncommon complication of a common condition. In their article in this issue Drs Saninand Mathew describe a patient with migrainous stroke and arteriographic findings consistent with diffuse cerebral

© 2010-2017 Pharmacy Pills Pdf